Home LiteratureArticle Details
PMID: 15229371 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S. Review

The challenge of type 1 diabetes mellitus.

ILAR journal ·Vol. 45 ·No. 3 ·2004-00-00 ·Pages 231-6

Eiselein L, Schwartz HJ, Rutledge JC

Abstract

Diabetes mellitus is a heterogeneous group of diseases characterized by high blood glucose levels due to defects in insulin secretion, insulin action, or both. With the number of cases expected to increase rapidly in the years to come, diabetes is a growing health challenge worldwide. Of the approximately 16 million diabetics in the United States, about 1.5 million suffer from type 1 diabetes. In this catabolic disorder afflicting predominantly young individuals, blood insulin is almost completely absent, leading to hyperglycemia and alterations in lipid metabolism. Type 1 diabetes is thought to be induced by a toxic or infectious insult that occurs in genetically predisposed individuals. With recent advances in the understanding of the involved immunology and cellular and molecular mechanisms, researchers strive to battle the disease with new preventive and corrective strategies.

MeSH Terms
Diabetes Complications Diabetes Mellitus, Type 1/epidemiology,etiology,pathology,therapy Humans United States/epidemiology
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Eiselein Larissa
Molecular, Cellular and Integrative Physiology Graduate Group, University of California, Davis, CA, USA.
Schwartz Henry J
Rutledge John C
Article Info
Journal
ILAR journal
Abbr.
ILAR J
ISSN
1084-2020
Published
2004-00-00
Pages
231-6
Language
English
Region
England
NLM ID
9516416
Subset
IM
Grants
NHLBI NIH HHS · HL55667 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com